Page last updated: 2024-08-26

fotemustine and Brain Damage, Chronic

fotemustine has been researched along with Brain Damage, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Geissler, A; Gruss, C; Landthaler, M; Schalke, B; Stolz, W	1

Other Studies

1 other study(ies) available for fotemustine and Brain Damage, Chronic

Article	Year
Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation. Melanoma research, 2002, Volume: 12, Issue:4 Topics: Antineoplastic Agents, Alkylating; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dementia; Humans; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Quality of Life; Radiotherapy, High-Energy; Remission Induction	2002

Article

Year

Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation.

Melanoma research, 2002, Volume: 12, Issue:4

Topics: Antineoplastic Agents, Alkylating; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dementia; Humans; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Quality of Life; Radiotherapy, High-Energy; Remission Induction

2002